childhood
communityacquir
pneumonia
cap
common
seriou
health
care
problem
respons
one
fifth
children
death
around
world
million
occur
develop
countri
europ
north
america
annual
incid
cap
approxim
case
per
therefor
also
repres
major
caus
morbid
two
major
difficulti
diagnosi
cap
first
one
defin
pneumonia
particularli
young
age
group
pneumonia
viral
lower
respiratori
tract
infect
common
condit
world
health
organ
defin
pneumonia
subsequ
treatment
strict
clinic
sign
tabl
prospect
studi
show
guidelin
also
appli
develop
countri
recommend
guidelin
british
thorac
societi
bt
second
difficulti
identifi
caus
agent
pneumonia
children
remain
challeng
number
reason
endotrach
aspir
obtain
routin
nasopharyng
swab
ns
show
colon
normal
flora
includ
bacteria
commonli
caus
pneumonia
bacteremia
demonstr
less
bacteri
cap
therefor
etiolog
cap
remain
often
unknown
consequ
mani
children
get
antibiot
treatment
nonbacteri
infect
contribut
increas
bacteri
resist
antibiot
aim
studi
perform
routin
implement
heptaval
pneumococc
vaccin
switzerland
defin
strictli
possibl
caus
agent
pneumonia
among
children
age
month
year
hospit
cap
basi
clinic
criteria
determin
factor
could
help
clinician
discrimin
bacteri
viral
pneumonia
particip
prospect
descript
studi
offer
consecut
children
age
month
year
old
present
cap
accord
criteria
tabl
consecut
admit
children
unit
univers
hospit
lausann
geneva
march
decemb
classifi
accord
initi
sever
children
activ
treat
asthma
underli
chronic
diseas
immunosuppress
wheez
exclud
children
wheez
specif
exclud
wheez
consid
symptom
asthma
andor
viral
bronchiol
pneumonia
therefor
children
treat
antibiot
cough
fever
associ
sign
symptom
use
antibiot
month
admiss
main
featur
clinic
cours
record
ethic
committe
institut
approv
studi
protocol
sign
consent
obtain
inform
parent
admiss
blood
sampl
taken
total
white
blood
cell
count
wbc
manual
verifi
differenti
count
serum
crp
pct
brahm
berlin
germani
measur
senior
radiologist
blind
clinic
laboratori
find
review
chest
radiograph
assign
standard
descript
xray
propos
work
group
presenc
consolid
pleural
effus
parenchym
infiltr
defin
pneumonia
admiss
start
antibiot
treatment
peripher
blood
cultur
winter
epidem
rapid
antigen
detect
test
rsv
cori
becton
dickinson
perform
within
h
admiss
nasopharyng
aspir
npa
obtain
respiratori
physiotherapi
viral
bacteri
cultur
pcr
analysi
viral
antigen
detect
pcr
analysi
perform
mycoplasma
pneumonia
chlamydia
pneumonia
rtpcr
assay
perform
virus
includ
influenza
b
rsv
b
rhinoviru
parainfluenza
enteroviru
human
metapneumoviru
coronaviru
nl
previous
describ
present
studi
assay
use
qualit
tool
pcr
pneumonia
c
pneumonia
done
multiplex
realtim
pcr
accord
welti
et
al
viral
antigen
detect
perform
adenoviru
parainfluenza
rsv
influenza
b
indirect
immunofluoresc
argen
antibodi
elisa
serum
sampl
taken
admiss
approxim
week
hospit
store
subsequ
transport
dri
ice
laboratori
laboratori
unawar
clinic
data
antibodi
influenza
b
parainfluenza
rsv
adenoviru
pneumonia
detect
complement
fixat
method
pair
sampl
test
run
acut
infect
defin
fourfold
rise
titer
higher
serolog
test
c
pneumonia
done
use
microimmunofluoresc
test
mrl
diagnost
fourfold
rise
acut
convalesc
sera
initi
titer
higher
fourfold
posit
cut
valu
consid
indic
recent
infect
previous
describ
serum
igg
antibodi
pneumolysin
measur
indirect
elisa
antigenco
immulon
plate
thermo
labsystem
follow
min
incub
result
compar
pool
purifi
human
immunoglobulin
endobulin
baxter
use
standard
express
elisa
unitsml
sampl
rise
greater
twofold
acut
convalesc
sera
andor
acut
serum
antibodi
titer
greater
euml
score
posit
limit
previous
demonstr
reliabl
method
serolog
diagnosi
pneumococc
exposur
blood
sampl
taken
time
admiss
sera
frozen
order
analyz
second
phase
detect
pneumonia
perform
realtim
pcr
taqman
method
specif
target
pneumolysin
gene
briefli
blood
specimen
prelys
lysi
buffer
bacteri
lysi
buffer
roch
diagnost
cocktail
enzym
enzymmix
roch
diagnost
incub
period
min
sampl
automat
extract
magna
pure
compact
instrument
use
magna
pure
compact
isol
kit
five
microlit
elut
dna
amplifi
triplic
taqman
abi
prism
sequenc
detector
appli
biosystem
signific
curv
cycl
consid
posit
signal
posit
cut
defin
copyml
criteria
viral
infect
posit
viral
cultur
viral
antigen
posit
viral
serolog
viral
pcr
bacteri
infect
consid
blood
cultur
pleural
fluid
cultur
pneumococc
pcr
serolog
assay
posit
atyp
typic
bacteria
group
togeth
subject
criteria
viral
bacteri
infect
consid
infect
mix
etiolog
patient
treat
cours
parenter
antiobiot
first
cefuroxim
n
ceftriaxon
n
amoxiclavulan
acid
n
floxapen
n
follow
oral
antibiot
amoxiclavulan
acid
cefuroxim
total
durat
day
parenter
cefuroxim
initi
associ
clarithromycin
four
patient
switch
vancomycin
amoxyclavulan
acid
amoxycillin
clindamycin
two
patient
pleural
effus
data
analyz
use
epi
info
center
diseas
control
prevent
atlanta
ga
usa
standard
parametr
nonparametr
statist
test
done
accord
distribut
varianc
studi
variabl
level
statist
signific
defin
p
kappa
statist
comput
use
pair
modul
version
pepi
window
softwar
total
children
elig
studi
period
ninetynin
children
final
enrol
six
patient
exclud
imposs
obtain
sampl
initi
consent
five
parent
decid
interrupt
studi
among
patient
femal
averag
age
month
accord
criteria
nine
patient
requir
hospit
nonsever
pneumonia
patient
sever
pneumonia
sever
pneumonia
subject
fever
recent
histori
fever
tachypnea
mani
patient
show
number
symptom
cough
feed
difficulti
vomit
abdomin
pain
symptom
tired
apathi
n
thorac
pain
n
upper
respiratori
symptom
ur
rhiniti
n
sore
throat
n
ear
pain
n
averag
temperatur
admiss
breath
sound
abnorm
patient
dehydr
antibiot
given
patient
day
hospit
although
larg
variat
number
monthli
hospit
clear
season
pattern
observ
averag
durat
hospit
day
rang
hour
day
twentysix
children
requir
supplement
oxygen
therapi
nine
patient
need
gastric
feed
tube
nine
thorac
drainag
three
patient
transfer
pediatr
intens
care
unit
two
requir
noninvas
assist
ventil
tabl
tabl
show
number
sampl
obtain
test
viral
atyp
bacteri
serolog
difficult
obtain
followup
blood
sampl
well
nasopharyng
aspir
npa
notabl
children
without
upper
respiratori
tract
involv
potenti
caus
agent
detect
patient
evid
bacteri
infect
alon
demonstr
patient
viral
infect
alon
case
mix
bacterialvir
infect
found
patient
fig
one
patient
posit
blood
cultur
pneumonia
three
blood
cultur
contamin
coagulaseneg
staphylococci
one
patient
group
streptococcu
pleural
fluid
cultur
overal
bacteria
without
coinfect
pathogen
identifi
case
patient
pneumococc
pneumonia
diagnos
patient
overal
base
pcr
rise
antibodi
titer
andor
high
antibodi
titer
admiss
despit
neg
pcr
patient
serolog
evid
acut
pneumococc
infect
singl
child
pneumococc
bacteremia
posit
pcr
serolog
pneumonia
diagnos
alon
patient
bacteri
etiolog
mix
pneumococcalvir
infect
occur
patient
mix
pneumonia
larg
spectrum
concomit
virus
tabl
overal
among
children
evid
acut
viral
infect
fig
tabl
pcr
sensit
detect
sever
virus
patient
neg
viral
pcr
could
viral
infect
detect
use
anoth
method
signific
relationship
age
etiolog
categori
tabl
exclud
patient
undetermin
etiolog
univari
analys
show
dehydr
clinic
sign
significantli
repres
bacteri
group
pneumonia
inde
children
bacteri
pneumonia
mix
group
viral
pneumonia
group
p
show
sign
dehydr
tabl
symptom
significantli
associ
etiolog
particular
ur
significantli
frequent
viral
group
proport
patient
clinic
sever
categori
stage
differ
significantli
accord
etiolog
p
analysi
laboratori
data
show
children
bacteri
pneumonia
overal
higher
inflammatori
paramet
crp
pct
valu
significantli
higher
bacteri
pneumonia
group
mix
bacteri
pneumonia
analyz
togeth
tabl
howev
inflammatori
indic
statist
associ
clinic
sever
cut
level
mgl
sensit
crp
specif
low
cut
level
ngml
sensit
pct
specif
total
white
blood
cell
count
band
form
significantli
associ
etiolog
proport
children
treat
antibiot
hospit
differ
accord
etiolog
categori
chi
squar
p
averag
durat
hospit
relat
clinic
sever
admiss
breath
sound
describ
complet
normal
patient
patient
abnorm
auscult
constant
sign
diminish
breath
sound
patient
chest
xray
abnorm
patient
radiolog
consolid
present
patient
overal
percent
agreement
presenc
diminish
breath
sound
radiolog
consolid
kappa
coeffici
confirm
poor
agreement
associ
radiolog
descript
sever
etiolog
pneumonia
one
hundr
eleven
immunocompet
children
age
month
year
old
hospit
pneumonia
studi
prospect
elucid
factor
could
help
clinician
differenti
viral
bacteri
pneumonia
ninetynin
patient
met
inclus
criteria
strict
respect
definit
pneumonia
multipl
diagnost
approach
combin
microbiolog
serolog
biochem
assay
use
defin
spectrum
pathogen
caus
pneumonia
children
unimmun
pneumonia
overal
potenti
caus
agent
detect
children
confirm
previou
studi
show
test
done
potenti
caus
emerg
evid
bacteri
infect
demonstr
patient
pneumonia
document
case
corrobor
previou
report
one
michelow
et
al
viru
found
children
case
concurr
bacteri
viral
infect
found
antibiot
treatment
hospit
seem
factor
misdiagnosi
studi
show
children
fulfil
clinic
definit
pneumonia
sever
criteria
diagnosi
confirm
radiolog
consolid
case
poor
agreement
auscult
radiolog
consolid
confirm
poor
sensit
specif
auscult
diagnos
pneumonia
young
children
previous
describ
chest
xray
blood
cultur
help
discrimin
etiolog
categori
pneumonia
durat
hospit
correl
clinic
sever
essenti
criteria
defin
children
stage
iii
pneumonia
requir
oxygen
supplement
pain
clinic
sign
significantli
associ
bacteri
pneumonia
acutephas
surrog
marker
crp
pct
significantli
higher
bacteri
infect
regardless
presenc
absenc
coinfect
virus
corrobor
sever
previou
analys
even
find
controversi
recent
literatur
analysi
need
determin
exact
util
test
sensibl
specif
bacteri
cut
level
quit
low
final
data
could
show
signific
correl
clinic
sever
etiolog
pneumonia
report
previous
data
confirm
high
preval
virus
show
frequent
occurr
coinfect
childhood
cap
virus
commonli
found
rhinoviru
hmpv
confirm
recent
find
virus
frequent
involv
pediatr
cap
rsv
less
repres
report
probabl
patient
typic
bronchiol
strictli
exclud
sever
point
still
elucid
whether
virus
direct
caus
pneumonia
whether
creat
condit
favor
secondari
bacteri
infect
whether
presenc
play
rel
minor
role
cap
pathogenesi
main
limit
studi
lack
valid
standard
microbiolog
cut
valu
especi
concern
pneumonia
one
major
obstacl
improv
understand
cap
probabl
still
underdiagnos
pneumococc
possibl
bacteri
pneumonia
use
singl
antigen
pneumolysin
serolog
diagnosi
pneumococc
pneumonia
may
limit
well
difficulti
studi
obtain
convalesc
serum
sampl
avail
children
therefor
remain
difficult
distinguish
real
acquir
infect
recent
colon
recent
describ
nakayama
et
al
use
pcr
detect
bacteri
pneumonia
could
use
addit
diagnost
method
howev
fact
young
children
cap
requir
hospit
demonstr
evid
acut
pneumococc
infect
accord
demonstr
impact
pneumococc
immun
final
result
support
hypothesi
clinic
sever
depend
causal
agent
howev
ethic
practic
reason
chose
studi
hospit
children
therefor
limit
number
patient
stage
pneumonia
usual
treat
ambulatori
set
studi
includ
group
order
confirm
greater
number
patient
nonassoci
clinic
sever
admiss
etiolog
conclus
studi
use
strict
clinic
criteria
select
suitabl
subject
undergo
extens
microbiolog
etiolog
workup
use
complet
set
modern
diagnost
tool
data
confirm
high
preval
virus
frequent
occurr
coinfect
childhood
cap
dehydr
surrog
marker
inflamm
crp
pct
significantli
higher
children
bacteri
pneumonia
therefor
analys
perform
order
find
children
treat
antibiot
children
antibiot
could
withheld
safe
high
proport
pneumonia
sever
cap
reemphas
import
pneumococc
immun
antibiot
treatment
cap
young
children
studi
also
perform
evalu
epidemiolog
moder
sever
bacteri
pneumonia
introduct
pneumococc
immun
